Market
Primary target region for AI-created treatment deployment by end of 2025?
2
Resolution / Starting Odds
Africa • 25%
South America • 25%
Southeast Asia • 25%
Other • 25%
Official announcements or credible news reports
Story
AI Creates Experimental Treatment for Neglected Disease, Aiming to Democratize Drug Discovery by David Baker's Team
Jan 16, 2025, 12:08 PM
Researchers have developed an experimental treatment for a neglected disease using artificial intelligence, marking a significant advancement in drug discovery. The project, led by Nobel laureate David Baker and researcher Susana Vaz Torres, aims to 'democratize' the development of therapies that have been largely ignored by major pharmaceutical companies. This breakthrough was achieved through the application of AI technologies in the discovery process, showcasing the potential of AI to transform healthcare and address unmet medical needs.
View original story
Similar markets
Genomics Research • 25%
Drug Discovery • 25%
Healthcare Operations • 25%
Digital Pathology • 25%
Asia • 25%
Other • 25%
Europe • 25%
North America • 25%
South America • 25%
Other • 25%
Southeast Asia • 25%
Sub-Saharan Africa • 25%
Other regions • 25%
United States • 25%
Asia-Pacific • 25%
European Union • 25%
Africa • 25%
Asia • 25%
South America • 25%
North America • 25%
China • 25%
Other • 25%
United States • 25%
Europe • 25%
Other • 25%
Europe • 25%
North America • 25%
Asia • 25%
Other • 25%
Asia • 25%
Europe • 25%
North America • 25%
Hypertension • 25%
Cancer • 25%
Chronic Obstructive Pulmonary Disease (COPD) • 25%
Diabetes • 25%
Other • 25%
Heart Disease • 25%
Neurodegenerative Diseases • 25%
Cancer • 25%
Infectious diseases • 25%
Cancer • 25%
Other • 25%
Neurological disorders • 25%
Other • 25%
Asia • 25%
Europe • 25%
North America • 25%